semaglutide snac Semaglutide, the First Oral GLP-1 for Type 2 Diabetes Combining SNAC and C10 in

A lipid-based partitioning mechanism for selective incorporation of proteins into membranes of HIV particles

FDA Telehealth Warning Letters In early March 2026, the FDA reportedly issued warning letters to multiple telehealth companies regarding compounded GLP-1 marketing practices, with concerns including misleading marketing claims, implications of equivalence with FDA-approved drugs, and obscuring product sourcing

Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial

Key takeaways GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone that helps reduce appetite, regulate blood sugar levels and slow digestion

We discuss key translational challenges, including scalable manufacturing processes, quality control of particle size, ligand density, and release kinetics, and long-term biosafety concerns associated with inorganic materials and immune activation